P105 Clinical outcomes associated with infected totally implantable venous access devices

Applying Totally Implantable Venous Access Devices (TIVAD) in Children: the First Iranian Experience

Insertion of Totally Implantable Central Venous Access Devices by Surgeons

PURPOSE The aim of this study is to evaluate the results for the insertion of totally implantable central venous access devices (TICVADs) by surgeons. METHODS Total 397 patients, in whom TICVADs had been inserted for intravenous chemotherapy between September 2008 and June 2014, were pooled. This procedure was performed under local anesthesia in an operation room. The insertion site for the T...

applying totally implantable venous access devices (tivad) in children: the first iranian experience

0

Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications.

BACKGROUND Totally implantable vascular access devices (TIVADs) are accepted as a safe and effective method of facilitating long term intravenous therapy. We report our experience of the use of these devices in children with cystic fibrosis with a particular focus on the incidence and type of complications. METHODS The medical records of patients with cystic fibrosis who underwent placement o...

Totally implantable venous access devices in cystic fibrosis: complications and patients' opinions.

The introduction of totally implantable venous access devices (TIVAD) has provided a solution to difficult venous access in patients with cystic fibrosis. Early reports have, however, recognized a number of complications with their use. We report our experience with five devices used over 8 yrs with regard to complications and patient attitudes. Patients' notes were reviewed to record the detai...